NL-OMON56801尚未招募不适用
Immune sparing Radiotherapy strategies In head and neck Squamous cell carcinoma (IRIS) - IRIS study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients with mucosal squamous cell carcinoma of the head and neck amenable for
- •radiotherapy
排除标准
- •Previously treated by irradiation in the head and neck region
- •Chronic inflammatory disease or immune disorders
- •Other malignant disease (unless in situ carcinoma or BCC) within the last 2
研究者
相似试验
进行中（未招募）
1 期
Stereotactic body radiotherapy with immunotherapy in early stage non-small cell lung cancer: tolerability and lung effectson small-cell lung cancer (NSCLC) Stage: T1-3( =5cm)N0M0)EUCTR2016-005187-34-GBThe Royal Marsden NHS Foundation Trust31
招募中
2 期
eoadjuvant Immune-Chemo-Radiotherapy in operable oEsophageal and gastro-oesophageal junction cancers with Carboplatin Paclitaxel Radiotherapy and Avelumab - a Trial assessing feasibility and preliminary EfficacyOesophageal cancergastro-oesophageal junction cancerCancer - Oesophageal (gullet)ACTRN12619000288123Southern Adelaide Local Health Network Inc52
已完成
不适用
Combined Local Immunotherapy and Radiotherapy in metastatic MelanomaMetastatic melanomaMalignant melanoma of skinCancerISRCTN26232057St George's Healthcare NHS Trust (UK)30
招募中
不适用
Parotid Sparing Adaptive RadiotherapyCTRI/2017/11/010683Tata Medical Centre
进行中（未招募）
1 期
Investigation of the efficacy of radiotherapy and azathioprine in combination with a standard course of steroids in patients with active thyroid eye diseaseThyroid Eye DiseaseEUCTR2004-002547-27-GBniversity of Bristol160